The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-UK detects South African coronavirus variant in people with no travel links

Mon, 01st Feb 2021 12:28

* Eleven cases in England with no direct connection with S.
Africa

* Public Health England says 105 cases of new variant
detected

* Mass testing to start in eight areas to contain spread
(Adds comments from health secretary, Public Health England)

By Paul Sandle

LONDON, Feb 1 (Reuters) - Eleven people in different regions
of England have tested positive for the South African
coronavirus variant without having any links to people who have
travelled, prompting mass testing in the areas to contain the
outbreak.

Britain, with the world's fifth-highest COVID-19 death toll,
has moved to tighten its borders out of concern that new
variants of the virus will undermine its vaccination drive.

To contain the new outbreaks, residents in eight areas of
the country will now be tested whether or not they are showing
symptoms, a process known as "surge testing".

There are about 10,000 people in each area. Three are in
London, two in the southeast, one in central England, one in the
east and another in the northwest.

Health minister Matt Hancock said those in the affected
areas needed to comply with the request to be tested, even if
they are asymptomatic, to break any chain of transmission.

"There's currently no evidence to suggest this variant is
any more severe," he said. "But we need to come down on it hard,
and we will."

Positive tests in the areas will be sequenced to identify
any further spread of the variant.

All viruses mutate, and scientists have identified several
variants of the coronavirus found to be more transmissible than
the original strain.

Their emergence has raised questions over whether vaccines
will still prove effective.

Public Health England said it has identified a total of 105
cases of the South African variant since Dec 22.

Scientists have said it appears to be more transmissible,
but there is no evidence that it causes more severe disease.
However, several laboratory studies have found that it reduces
vaccine and antibody therapy efficacy.

Simon Clarke, associate professor in cellular microbiology
at the University of Reading, said there was emerging evidence
to suggest the variant was less susceptible to immunity induced
by the current crop of vaccines.

"The discovery of a handful of cases with no links to travel
to Africa indicates that it might be more widespread in the
community than previously thought," he said.

"This spread, even if small in scale, needs to be brought
under control quickly, so Public Health England's house-to-house
checks and intensive testing are the right thing to do."

Public Health England's Managing Director Susan Hopkins said
the cases did not appear linked.

"They're more likely to be related to somebody who
potentially had asymptomatic infection when they came in from
abroad," she said at a news conference.

Britain is battling a new wave of COVID-19 turbocharged by
the emergence in September of a more transmissable variant found
in the southeast of England. The country's official death toll
passed 100,000 last week.
Britain is, however, making rapid progress in its vaccination
programme, with nearly 9.3 million people having received the
first shot of either the Pfizer-BioNTech or
Oxford-AstraZeneca shot.
(Reporting by Kate Holton, Michael Holden and Paul Sandle
Editing by Estelle Shirbon, Timothy Heritage and David Goodman
)

More News
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.